MicroPort MedBot 微创机器人
"Explore unknown, shaping the era of super intelligent surgery."
Shanghai-founded global medtech group (HKEX: 00853) whose MedBot subsidiary makes Toumai, the world's first approved commercial tele-surgery robot.
Shanghai MicroPort MedBot (Group) Co., Ltd. is a Chinese surgical robotics company that began developing laparoscopic surgical robots in 2014 as an internal incubation project of the MicroPort Group and was incorporated in Shanghai in 2015.
The company develops comprehensive intelligent surgical solutions by integrating robot mechanics, control algorithms, electrical engineering, image-based navigation and precision imaging. MicroPort MedBot describes itself as covering five subsectors of surgical robotics—endoscopy (laparoscopy), orthopedics, pan-vascular intervention, trans-natural-orifice surgery and percutaneous puncture—plus medical aesthetics solutions. Its flagship Toumai laparoscopic surgical robot became the first domestic four-arm laparoscopic surgical robot approved by China's NMPA in 2022, received EU CE certification, and has been used in telesurgery including 5G ultra-remote and cross-border procedures; the SkyWalker orthopedic joint-replacement robot, Honghu orthopedic robot, DFVision 3D electronic laparoscope, Mona Lisa percutaneous puncture robot and the R-ONE vascular robot complete the portfolio.
Toumai has gained access in over 60 countries and regions and surpassed 100 cumulative global commercial orders by late 2025. The company was renamed Shanghai MicroPort Medbot (Group) Co., Ltd. in 2021 and listed on the Main Board of the Hong Kong Stock Exchange that year. Headquarters are at 1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Shanghai.
Primary type & automation activities this supplier delivers:
Toumai Laparoscopic Surgical Robot
- Model: Toumai
- Launch Year: 2022
Four-arm laparoscopic surgical robot supporting 5G telesurgery; first domestic NMPA-approved system.
SkyWalker Orthopedic Surgical Robot
Hip and knee joint-replacement orthopedic surgical robot with NMPA certification and global use.
Honghu Orthopedic Surgical Robot
- Model: Honghu
- Launch Year: 2022
Chinese-developed orthopedic robot with proprietary robotic arms; NMPA, CE and FDA cleared.
DFVision 3D Electronic Laparoscope
- Model: DFVision
- Launch Year: 2021
3D electronic laparoscope for minimally invasive surgical imaging, NMPA and CE certified.
More related news
-
1
RobotToday Weekly October 5 – 9, 2026 RobotToday · 12hs ago
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
-
10
Robotics Investing: Intuitive Surgical or Unitree? RobotToday · Aug 31, 2026
- 11
-
12
AI for Science 2026: The Global Race for Scientific Discovery RobotToday · Jul 19, 2026
-
13
2026H2 Robotics Events Briefing: Tailored Recommendations for Robotics Readers RobotToday · Jul 05, 2026
-
14
Automate 2026 | Ubicept Explores Photon-Level Machine Vision RobotToday · Jun 29, 2026
-
15
The EV Déjà Vu: Why China's Humanoid Robot Blitz May Be Winning the Battle — but Losing the War RobotToday · Jun 28, 2026
-
16
ROBOTTODAY Weekly June 23 – 27, 2026 RobotToday · Jun 27, 2026
- 17
-
18
Capex Analysis 2025: AI Hyperscalers vs Humanoid Robots — Financing Risk Deep Dive RobotToday · Jun 23, 2026
-
19
CONSTRUCTION ROBOTICS | FUTURE HORIZONS: 2025–2030 & BEYOND RobotToday · Jun 12, 2026
- 20
Contact MicroPort MedBot
WEBSITE
https://microport.comPHONE
+86 21 389 54600HEADQUARTERS
China
Company Facts
Founded
2015
Primary Role
Manufacturer
Company Size
-
Primary Region
Asia-Pacific
Annual Sales
-
Funding Stage
Public
Funding Total
-
Certifications & Memberships
